• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD. ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD. ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Catalog Number ZIV6-35-125-6.0-120-PTX
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Occlusion (1984); Claudication (2550); Surgical procedure, additional (2564)
Event Date 04/28/2014
Event Type  Injury  
Event Description
On (b)(6) 2012, three ptx stents were placed in right sfa; 2x ziv6-35-125-6.0-120-ptx and 1x ziv6-35-125-6.0-40-ptx.On (b)(6) 2014, restenosis (50-99%) in the lesion where the complaint stents were implanted was confirmed, which extended throughout all the three stents.Worsen claudication and worsen rutherford were observed to the patient.Pta was performed against the restenosis on (b)(6) 2014 and the patient recovered.This report relates to one of the ziv6-35-125-6.0-120-ptx devices.Reference also related mdr reports 3001845648-2014-00265 and 3001845648-2014-00267 for the other two devices.
 
Manufacturer Narrative
Pma/510(k)#: p100022/s001.(b)(4).This incident meets the reported criteria of a fda mdr report based on intervention carried out (pta was performed) as a result of the occurrence of restenosis while a zilver ptx stent was indwelling.This investigation addresses 1 x ziv6-35-125-6.0-120-ptx of lot c775583.The zilver ptx device involved in this complaint was implanted in the patient therefore is not available for evaluation.With the information provided, a document based investigation was carried out.Images were not available to support the complaint investigation.It may be noted that re-stenosis is a common adverse event of endovascular procedures and can be caused by injury to the vessel (e.G.During pta and/or stenting).Vessel injury provokes an inflammatory response that leads (or amplifies)to the restenosis process.Restenosis of the stented artery is a known potential adverse event associated with the placement of the device.A review of the manufacturing records for ziv6-35-125-6.0-120-ptx device of lot #c775583 revealed no discrepancies related to this complaint issue.Prior to distribution, all zilver ptx devices are subject to visual inspection and functional checks t ensure device integrity.Since there are no images available for review, there is no evidence to suggest that re-stenosis did not occur; therefore, the complaint is confirmed based on customer testimony.Pta was performed on the patient and the patient recovered.Complaints of this nature will continue to be monitored for emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX DRUG-ELUTING PERIPHERAL STENT
Type of Device
NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
COOK IRELAND LTD.
limerick
EI 
Manufacturer Contact
sinead burke, unk
3536133444
MDR Report Key4314882
MDR Text Key5251174
Report Number3001845648-2014-00266
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 10/31/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/25/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2014
Device Catalogue NumberZIV6-35-125-6.0-120-PTX
Device Lot NumberC775583
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date04/28/2014
Event Location Hospital
Date Manufacturer Received10/31/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/11/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age82 YR
-
-